GSK and Enigma Diagnostics announce collaboration
10 August 2011 | By GlaxoSmithKline
GSK & Enigma Diagnostics have signed agreements for the supply & commercialisation of the Enigma® ML system...
List view / Grid view
10 August 2011 | By GlaxoSmithKline
GSK & Enigma Diagnostics have signed agreements for the supply & commercialisation of the Enigma® ML system...
10 August 2011 | By The Scott Partnership
The University of Kansas (KU) implement Greenphire's patent-pending ClinCard System...
10 August 2011 | By Boehringer Ingelheim
Boehringer Ingelheim and ProBioGen AG have signed a non-exclusive Licensing Agreement regarding ProBioGen’s GlymaxX® technology...
10 August 2011 | By Gilead Sciences Inc
A new complete once-daily, single-tablet regimen for HIV-1 infection in treatment-naïve adults...
9 August 2011 | By Eli Lilly and Company
Eli Lilly and Company announced that data on EVISTA® (raloxifene HCl tablets) therapy for more than three years was published...
9 August 2011 | By Abbott
Biogen Idec and Abbott announced positive top-line results from SELECT, a global, registrational Phase 2b clinical trial...
9 August 2011 | By The Scott Partnership
PRECOS, has signed a partnership agreement with RCT to provide scientific validation of existing data for cancer therapies...
9 August 2011 | By GlaxoSmithKline
GSK and XenoPort, Inc. request approval of Horizant™...
9 August 2011 | By Boehringer Ingelheim
The pharmaceutical company Boehringer Ingelheim has in the first half of 2011 once again grown in local currency terms compared to the previous year (+ 4 percent). Due to negative foreign exchange effects, consolidation in euros shows growth of 2.6 percent, with total net sales of EUR 6.4 billion against…
8 August 2011 | By Gilead Sciences Inc
Gilead Sciences, Inc. has signed a definitive agreement...
8 August 2011 | By Pfizer
Five year partnership With UC San Diego Health Sciences to accelerate drug discovery and development...
5 August 2011 | By The Scott Partnership
Molecular Profiles, a leading provider of pharmaceutical development services, has announced that Nikin Patel, CEO, has been acknowledged as one of PharmaVOICE magazine’s top 100 most inspiring individuals in the life sciences industry...
5 August 2011 | By Takeda Pharmaceutical Company Limited
Collaboration will explore potential of other assets to address obesity epidemic...
4 August 2011 | By Ogilvy Healthworld UK Limited
Pradaxa®1 (dabigatran etexilate) approved...
4 August 2011 | By NSF
NSF is launching NSF Reference Standards™...